C$0.04 AIML.CN AI/ML Innovations CNQ Feb 21 2026: watch catalysts for upside

We see AI/ML Innovations Inc. (AIML.CN) trading at C$0.04 on the CNQ on 21 Feb 2026, and liquidity has picked up with 455,400.00 shares changing hands today. AIML.CN stock sits near its year low of C$0.03 and well below the year high of C$0.12, reflecting low market confidence. We examine valuation, technicals, Meyka AI forecasts, and key sector context for investors focused on AI stocks in healthcare.

Price and market data for AIML.CN stock

AIML.CN stock closed at C$0.04 with volume 455,400.00 and average volume 388,552.00. Market cap stands at C$6,730,560.00 and shares outstanding are 168,264,000.00. The 50-day average price is C$0.04 and the 200-day average is C$0.05, showing recent weakness versus longer-term price action.

Fundamentals and valuation for AIML.CN stock

AI/ML Innovations reports negative earnings with EPS -0.03 and a trailing PE of -1.33, reflecting losses. Key ratios include a price to sales near 40.00 and price to book at 5.23, which imply a valuation premium despite weak revenue per share 0.00. Current ratio is 2.09, showing short-term coverage, but margins remain negative with net margin -39.10%.

Technicals and trading signals on AIML.CN stock

Technical indicators show neutral to mild bullish momentum: RSI 59.10 and ROC 14.29%. Bollinger Bands sit tight at 0.03–0.04, and ADX at 15.50 signals no strong trend. Trading volume today is slightly above average, suggesting increased interest, but ATR is effectively 0.00, meaning price moves are still compressed.

Meyka grade, model forecast, and AIML.CN stock outlook

Meyka AI rates AIML.CN with a score out of 100: 62.19 (Grade B) — HOLD. This grade factors S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of C$0.02 and a yearly level near C$0.00843. Compared with the current C$0.04, the model implies a monthly downside of -50.00% and a yearly downside of -78.92%. Forecasts are model-based projections and not guarantees.

Risks and opportunities for AIML.CN stock

Risk factors include small market cap (C$6.73M), negative earnings, thin float and possible dilution. Opportunities center on the company’s AI-driven wearable health platform and patent pending technology that could win clinical partnerships. Sector context matters: healthcare AI interest can lift small names on trial or pilot wins, while broader healthcare sector weakness can pressure AIML.CN stock.

Price targets, analyst stance, and short-term strategy for AIML.CN stock

There is no consensus price target available. Given current fundamentals, a pragmatic short-term price target for traders is C$0.08 as an optimistic technical rebound and C$0.02 as a downside near-term support. Analysts should treat AIML.CN stock as speculative. We recommend position sizing, milestone-based re-evaluation, and monitoring company announcements closely.

Final Thoughts

AIML.CN stock trades at C$0.04 on the CNQ in Canada and shows both speculative upside potential and clear downside risk. Fundamentals are weak: EPS -0.03, PE -1.33, price to sales 40.00, and small market cap C$6,730,560.00. Technicals show short-term interest with RSI 59.10 and volume above average, but the absence of strong trend momentum raises caution. Meyka AI’s internal grade gives AIML.CN a 62.19/100 (B, HOLD) after comparing sector peers, metrics, and forecasts. Meyka AI’s forecast model projects monthly C$0.02 and yearly C$0.00843, implying model-based downside versus the current price; these projections are not guarantees. For AI stock investors, AIML.CN is a high-risk, event-driven holding: consider tight sizing, watch for clinical or partnership news, and use stop-loss rules. We will monitor company filings and sector moves and update as new catalysts appear. Meyka AI provides this note as an AI-powered market analysis platform and not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.